News & Press

In a step toward the full realization of genomic medicine, Fabric Genomics, a leader in AI-based genomic analysis and interpretation, has announced a co-marketing agreement that will provide translational researchers around the world with integrated sample prep to reporting workflows. Combining Roche’s newly released KAPA HyperExome Probes (RUO) with the

Fabric Genomics, a global leader in clinical interpretation of genomic data, announced today the launch of Fabric GEM, a novel algorithm that quickly and efficiently identifies the likely genetic cause of rare diseases from next-generation sequencing data – enabling faster diagnosis and the possibility of faster and more effective treatment.

Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced a

Researchers at Rady Children’s Institute for Genomic Medicine (RCIGM) and its partners, including Fabric Genomics, have today published in Science Translational Medicine a new study documenting the process to diagnose rare genetic diseases in record time. This new method speeds answers to physicians and allows increased use of genome sequencing

Fabric Genomics will launch a new solution this week for variant interpretation and clinical reporting, allowing clinical laboratories to dramatically accelerate turnaround times. This new software solution, called Fabric Hereditary Panels with ACE (AI Classification Engine), will debut at the ACMG annual meeting in Seattle, Washington. The solution incorporates an

  Booth #923 For Meetings, Contact: info@fabricgenomics.com

Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and their patients to complement Diagnomics’ portfolio of Personalized Genomics. Diagnomics has partnered with Fabric Genomics to use Fabric Enterprise, its clinical decision-support platform, to generate clinical insights for the report.

Fabric Genomics and Genomenon announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant classification. Fabric Genomics speeds and scales genomic interpretation by combining the most advanced AI algorithms with automated workflows, while Genomenon’s literature search engine facilitates comprehensive literature

Fabric Genomics announced today that it is offering select customers the option of using ‘Build 38,’ the most current reference genome assembly, for their clinical genetic testing efforts. Earlier this year, Fabric Genomics began providing the new reference genome in its platform to Genomics England, and is now offering other